Sustained Tear Film Exposure After Parenteral Cefovecin Administration in Dogs: Pharmacokinetics and Relevance to Canine Bacterial Keratitis
Open Access
- 2 August 2026
- journal article
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (5) , e70238
Abstract
Objective: To characterize the tear film pharmacokinetics of parenterally administered cefovecin (Convenia) and compare tear concentrations with the minimum inhibitory concentrations (MICs) of common ocular pathogens. Animals Studied: Six healthy research‐bred Beagles. Procedures: Dogs received a single subcutaneous injection of cefovecin (8 mg/kg) after inducing blood‐tear barrier disruption through histamine‐mediated conjunctivitis. Tear fluid was collected using Schirmer strips at multiple time points up to 336 h and analyzed via liquid chromatography–mass spectrometry. Tear concentrations from both eyes were averaged for analysis. MIC values were determined for Staphylococcus pseudintermedius , Streptococcus canis , and Pseudomonas aeruginosa ( n = 10 isolates per species). Results: In a pilot experiment ( n = 1 dog), tear cefovecin concentrations were 1.5 to 430‐fold higher in the conjunctivitis eye than in the control eye at all but one time point. Across all dogs, tear concentrations ranged from 68 to 73 035 ng/mL and remained detectable throughout the 336‐h study. Mean ± SD pharmacokinetic parameters were: C max 27.23 ± 27.74 μg/mL, T max 61 ± 83 h, AUC 2734 ± 2563 μg/mL·h, and t 1/2 64 ± 46 h. Tear concentrations exceeded the MIC 90 for Streptococcus (0.64 μg/mL) for 336 h and exceeded the MIC 90 for some Staphylococcus (10.2 μg/mL) between 48 and 120 h, but remained below the MIC 90 for Pseudomonas . Conclusions: Parenteral cefovecin achieved sustained tear concentrations sufficient to inhibit some susceptible Streptococcus and Staphylococcus isolates in vitro for clinically relevant time windows. While these findings support further investigation of cefovecin as an adjunctive therapy in selected cases, they do not justify empiric systemic antimicrobial use. Larger pharmacokinetic and clinical studies are warranted to validate these findings.Keywords
This publication has 33 references indexed in Scilit:
- Effects of antimicrobials on the gastrointestinal microbiota of dogs and catsThe Veterinary Journal, 2022
- Fluorophotometric Assessment of Tear Volume and Turnover Rate in Healthy Dogs and CatsJournal of Ocular Pharmacology and Therapeutics, 2019
- Long-term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogsJournal of Veterinary Internal Medicine, 2019
- Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without ConjunctivitisJournal of Ocular Pharmacology and Therapeutics, 2019
- Impact of Flow Rate, Collection Devices, and Extraction Methods on Tear Concentrations Following Oral Administration of Doxycycline in Dogs and CatsJournal of Ocular Pharmacology and Therapeutics, 2018
- Effect of Blinking on Tear Volume After Instillation of Midviscosity Artificial TearsAmerican Journal of Ophthalmology, 2008
- Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administrationJournal of Veterinary Pharmacology and Therapeutics, 2008
- Pharmacokinetics and pharmacodynamics of cefovecin in dogsJournal of Veterinary Pharmacology and Therapeutics, 2006
- Bacterial corneal diseases in dogs and catsClinical Techniques in Small Animal Practice, 2003
- Plasma and tear concentrations of antibiotics administered parenterally to cattleResearch in Veterinary Science, 1985